Literature DB >> 27695581

Survival after partial and radical nephrectomy for high-risk disease: A propensity-matched comparison.

Matthew J Maurice1, Hui Zhu2, Simon Kim3, Robert Abouassaly3.   

Abstract

INTRODUCTION: Increasingly, partial nephrectomy has been applied to high-risk disease without evidence that its survival benefits can be extrapolated to this entity. We aimed to compare overall survival after partial vs. radical nephrectomy in patients with high-risk renal cell carcinoma.
METHODS: Using the National Cancer Data Base, we identified patients who underwent partial or radical nephrectomy for high-risk disease between 2003 and 2006. High-risk disease was defined as the presence of adverse pathological features within the primary tumour, namely high-grade or unfavourable histology, T3 stage, or both. After matching the partial and radical nephrectomy groups based on propensity scores, 1680, 276, and 76 patients with high-grade or unfavourable histology, T3 stage, or both adverse pathologic features, respectively, were available for analysis. Five-year overall survival was compared after partial vs. radical nephrectomy for each high-risk cohort using the Kaplan-Meier and log rank tests.
RESULTS: Partial nephrectomy was associated with a statistically significant improvement in five-year overall survival compared to radical nephrectomy for small tumours (median size 3.0 cm; interquartile range 2.1-4.5 cm) with high-grade or unfavourable histology (87% vs. 81%; p<0.01) or with pT3a stage (82% vs. 71%; p<0.01). For patients concomitantly harbouring both adverse pathologic features, no difference in survival was detected (p=0.21).
CONCLUSIONS: Partial nephrectomy is associated with survival benefits in patients with adverse pathologic features, suggesting that renal preservation is not only safe, but also potentially beneficial for high-risk disease. Due to inherent selection bias associated with partial nephrectomy use, prospective validation of these findings is needed.

Entities:  

Year:  2016        PMID: 27695581      PMCID: PMC5028211          DOI: 10.5489/cuaj.3707

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  22 in total

1.  Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival.

Authors:  Christopher J Weight; Benjamin T Larson; Tianming Gao; Steven C Campbell; Brian R Lane; Jihad H Kaouk; Inderbir S Gill; Eric A Klein; Amr F Fergany
Journal:  Urology       Date:  2010-05-10       Impact factor: 2.649

Review 2.  Do we know (or just believe) that partial nephrectomy leads to better survival than radical nephrectomy for renal cancer?

Authors:  Conrad M Tobert; Christopher B Riedinger; Brian R Lane
Journal:  World J Urol       Date:  2014-03-27       Impact factor: 4.226

3.  Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2/pT3 or high-grade renal tumors compared with radical nephrectomy.

Authors:  Christopher J Weight; Casey Lythgoe; Raman Unnikrishnan; Brian R Lane; Steven C Campbell; Amr F Fergany
Journal:  Urology       Date:  2011-03-21       Impact factor: 2.649

4.  Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy.

Authors:  Jens Hansen; Maxine Sun; Marco Bianchi; Michael Rink; Zhe Tian; Nawar Hanna; Malek Meskawi; Jan Schmitges; Shahrokh F Shariat; Felix K-H Chun; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz
Journal:  Urology       Date:  2012-06-13       Impact factor: 2.649

5.  Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage.

Authors:  Kirk A Keegan; Clayton W Schupp; Karim Chamie; Nicholas J Hellenthal; Christopher P Evans; Theresa M Koppie
Journal:  J Urol       Date:  2012-06-13       Impact factor: 7.450

6.  Treatment management of small renal masses in the 21st century: a paradigm shift.

Authors:  Maxine Sun; Firas Abdollah; Marco Bianchi; Quoc-Dien Trinh; Claudio Jeldres; Rodolphe Thuret; Zhe Tian; Shahrokh F Shariat; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Ann Surg Oncol       Date:  2012-02-10       Impact factor: 5.344

7.  Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy.

Authors:  Rodney H Breau; Paul L Crispen; Rafael E Jimenez; Christine M Lohse; Michael L Blute; Bradley C Leibovich
Journal:  J Urol       Date:  2010-01-18       Impact factor: 7.450

8.  Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics.

Authors:  Claudio Jeldres; Jean-Jacques Patard; Umberto Capitanio; Paul Perrotte; Nazareno Suardi; Maxime Crepel; Vincenzo Ficarra; Luca Cindolo; Alexandre de La Taille; Jacques Tostain; Christian Pfister; Baptiste Albouy; Marc Colombel; Arnaud Méjean; Hervé Lang; Didier Jacqmin; Jean-Christophe Bernhard; Jean-Marie Ferrière; Karim Bensalah; Pierre I Karakiewicz
Journal:  Urology       Date:  2009-04-18       Impact factor: 2.649

9.  Increased use of partial nephrectomy to treat high-risk disease.

Authors:  Matthew J Maurice; Hui Zhu; Simon P Kim; Robert Abouassaly
Journal:  BJU Int       Date:  2015-09-28       Impact factor: 5.588

10.  Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?

Authors:  William C Huang; Elena B Elkin; Andrew S Levey; Thomas L Jang; Paul Russo
Journal:  J Urol       Date:  2008-11-13       Impact factor: 7.450

View more
  1 in total

1.  Comparison of oncologic outcomes between partial nephrectomy and radical nephrectomy in patients who were upstaged from cT1 renal tumor to pT3a renal cell carcinoma: an updated systematic review and meta-analysis.

Authors:  Doo Yong Chung; Dong Hyuk Kang; Jong Won Kim; Do Kyung Kim; Joo Yong Lee; Kang Su Cho
Journal:  Ther Adv Urol       Date:  2020-12-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.